Takeda Pharmaceutical Company Limited (LON:0A87)
London
· Delayed Price · Currency is GBP · Price in USD 13.41
-0.34 (-2.47%)
At close: Jan 31, 2025
LON:0A87 Ratios and Metrics
Market cap in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 35,389 | 34,363 | 41,118 | 33,976 | 40,888 | 38,468 | Upgrade
|
| Market Cap Growth | -4.94% | -16.43% | 21.02% | -16.91% | 6.29% | -21.03% | Upgrade
|
| Enterprise Value | 61,526 | 60,110 | 66,084 | 56,723 | 71,294 | 76,134 | Upgrade
|
| Last Close Price | 10.79 | 10.75 | 12.60 | 10.21 | 12.38 | - | Upgrade
|
| PE Ratio | 33.48 | 45.56 | 21.33 | 23.57 | 16.57 | 116.48 | Upgrade
|
| PS Ratio | 1.45 | 1.54 | 1.68 | 1.52 | 1.95 | 1.57 | Upgrade
|
| PB Ratio | 0.89 | 0.90 | 1.06 | 0.95 | 1.20 | 1.09 | Upgrade
|
| P/FCF Ratio | 7.23 | 12.14 | 8.08 | 5.42 | 6.92 | 9.50 | Upgrade
|
| P/OCF Ratio | 5.95 | 9.16 | 6.92 | 4.83 | 6.16 | 7.69 | Upgrade
|
| EV/Sales Ratio | 2.54 | 2.69 | 2.70 | 2.54 | 3.40 | 3.10 | Upgrade
|
| EV/EBITDA Ratio | 8.83 | 10.09 | 8.98 | 7.65 | 11.04 | 11.59 | Upgrade
|
| EV/EBIT Ratio | 19.69 | 23.28 | 17.54 | 15.09 | 25.62 | 34.38 | Upgrade
|
| EV/FCF Ratio | 13.21 | 21.23 | 12.99 | 9.06 | 12.07 | 18.79 | Upgrade
|
| Debt / Equity Ratio | 0.73 | 0.75 | 0.77 | 0.85 | 0.98 | 1.16 | Upgrade
|
| Debt / EBITDA Ratio | 4.13 | 4.60 | 3.86 | 4.07 | 5.16 | 6.21 | Upgrade
|
| Debt / FCF Ratio | 5.92 | 10.10 | 5.81 | 4.81 | 5.64 | 10.07 | Upgrade
|
| Asset Turnover | 0.31 | 0.29 | 0.30 | 0.27 | 0.25 | 0.25 | Upgrade
|
| Inventory Turnover | 1.31 | 1.30 | 1.36 | 1.40 | 1.34 | 1.33 | Upgrade
|
| Quick Ratio | 0.59 | 0.50 | 0.49 | 0.73 | 1.00 | 0.65 | Upgrade
|
| Current Ratio | 1.31 | 1.11 | 0.97 | 1.21 | 1.53 | 1.13 | Upgrade
|
| Return on Equity (ROE) | 2.94% | 2.12% | 5.27% | 4.24% | 7.60% | 0.89% | Upgrade
|
| Return on Assets (ROA) | 2.51% | 2.12% | 2.85% | 2.87% | 2.06% | 1.39% | Upgrade
|
| Return on Capital (ROIC) | 2.97% | 2.57% | 3.57% | 3.62% | 2.59% | 1.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.53% | 3.85% | 5.40% | 5.44% | 3.81% | 2.79% | Upgrade
|
| Earnings Yield | 2.99% | 2.19% | 4.69% | 4.24% | 6.04% | 0.86% | Upgrade
|
| FCF Yield | 13.17% | 8.24% | 12.37% | 18.44% | 14.44% | 10.53% | Upgrade
|
| Dividend Yield | 3.07% | 9.15% | 8.69% | 11.05% | 9.54% | - | Upgrade
|
| Payout Ratio | 145.09% | 199.34% | 88.14% | 123.30% | 75.36% | 638.73% | Upgrade
|
| Buyback Yield / Dilution | -1.17% | -0.67% | 0.46% | -0.23% | -0.47% | -61.98% | Upgrade
|
| Total Shareholder Return | 1.90% | 8.49% | 9.15% | 10.82% | 9.07% | -61.98% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.